查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1390570

2023-2028 年按技术（合成定序、连接定序、焦磷酸定序、桑格定序等）、研究类型、实验室类型、应用、最终用户和地区分類的微生物组定序服务市场报告

Microbiome Sequencing Services Market Report by Technology (Sequencing by Synthesis, Sequencing by Ligation, Pyrosequencing, Sanger Sequencing, and Others), Research Type, Laboratory Type, Application, End User, and Region 2023-2028
出版日期: | 出版商: IMARC | 英文 142 Pages | 商品交期: 2-3个工作天内

价格

抽象的

2022年，全球微生物组定序服务市场规模达到18.463亿美元。展望未来， IMARC Group预计到2028年市场规模将达到55.684亿美元，2022-2028年复合年增长率（CAGR）为20.20%。大众传染病发病率的增加、对基于微生物组的治疗（包括 FMT）的倾向不断增加，以及微生物组测序在兽医医学中的日益采用是推动市场的一些主要因素。

微生物组定序服务涉及对居住在包括人体在内的各种环境中的微生物群落进行分析。它们是专门的程序，旨在识别和分析生活在特定生态系统（例如人类肠道、土壤或水）中的多种微生物。他们使用先进的脱氧核糖核酸 (DNA) 定序技术来解码微生物的遗传物质，使研究人员和医疗保健专业人员能够了解这些微生物群落的组成、多样性和功能。

大众传染病发病率的不断上升，促进了对用于研究宿主与病原体关係的微生物组测序服务的需求，从而导致世界各地对其服务的需求不断增加。此外，人们越来越倾向于基于微生物组的治疗，包括粪便微生物群移植（FMT），这需要准确的微生物组分析以确保治疗效果和安全性，这有利于市场的成长。除此之外，兽医学中越来越多地采用微生物组定序来了解动物健康、疾病预防和改善畜牧生产，这对市场产生了积极影响。此外，製药业的扩张正在推动利用微生物组资料来开发新药，特别是针对胃肠道疾病的新药，这有助于市场成长。此外，越来越多地采用依赖数据驱动决策的精准农业实践，正在推动市场成长。

微生物组定序服务市场趋势/驱动因素：

个人化医疗和疗法的增加

随着个人化医疗的日益普及，对微生物组定序服务的需求不断增加，以便为个别患者提供量身定制的治疗和介入措施。对微生物组测序服务需求背后的驱动力之一是认识到一个人的每个微生物组都是独特的，并且可以显着影响他们对治疗的反应。无论是优化益生菌方案、指导饮食建议，或是预测药物疗效，微生物组资料都是不可或缺的。患者和医疗保健提供者越来越多地寻求这些见解，以实现更好的治疗结果、最大限度地减少不良反应并增强整体健康。因此，随着个人化医疗成为现代医疗保健的核心原则，对微生物组定序服务的需求不断增长。

消费者意识和健康的提高

消费者对微生物组在健康和保健中的作用的认识一直在稳步提高。人们对自己的健康变得更加积极主动，寻求优化微生物组以改善福祉的方法。这一趋势是由直接面向消费者的微生物组测试套件的可用性推动的，该套件为个人提供了对其肠道微生物群的深入了解。随着消费者更了解微生物组与各个健康面向之间的联繫，他们开始转向微生物组定序服务来进行深入分析和个人化建议。公众兴趣的激增正在推动对微生物组测序服务的需求，因为个人寻求做出明智的生活方式选择和饮食调整以促进更健康的微生物组。

不断增长的监管要求和品质保证

医疗保健、农业和食品安全领域的监管机构越来越认识到微生物组资料在确保安全和品质标准方面的重要性。例如，在食品工业中，微生物组定序用于透过识别潜在的病原体或腐败生物来监测和改善食品安全。同样，农业监管机构可能要求进行微生物组评估，以确保可持续的农业实践。遵守这些法规需要利用微生物组定序服务来维持高品质标准，从而导致企业和组织不断要求努力满足法规要求并确保其产品的安全性。

微生物组定序服务产业细分：

IMARC Group提供了对市场报告各细分市场主要趋势的分析，以及 2023 年至 2028 年全球、区域和国家层面的预测。我们的报告根据技术、研究类型、实验室类型、应用和最终用户对市场进行了分类。

按技术划分：

边合成边定序 (SBS)

连接定序 (SBL)

焦磷酸定序

桑格定序

其他的

边合成边定序 (SBS) 主导市场

该报告基于该技术对市场进行了详细的细分和分析。这包括边合成边定序 (SBS)、边连接边定序 (SBL)、焦磷酸定序、桑格定序等。根据该报告，合成定序（SBS）代表了最大的部分。 SBS 是微生物组定序服务背后的基础技术。它用于揭示给定样品中微生物的基因组成。在 SBS 过程中，微生物群落的 DNA 链被分解成各自的成分，然后精确地重建。这个过程依赖将萤光标记的核苷酸掺入到不断生长的 DNA 链中，这些链在添加时会发出不同的讯号。这些讯号被检测并转化为基因序列，使科学家能够识别样本中存在的微生物的类型和数量。 SBS 高度准确且高效，这使其成为微生物组分析的基石，应用范围从人类健康研究到环境监测。

依研究类型细分：

外包研究

内部研究

外包研究占市场最大份额

报告还根据研究类型对市场进行了详细的细分和分析。这包括外包研究和内部研究。报告称，外包研究占了最大的市场份额。在微生物组定序服务领域，研究常采用外包方法。这需要与拥有微生物组分析先进能力的外部研究合作伙伴或专业服务提供者合作。这些外包研究工作是由微生物组研究的复杂性和技术要求所驱动的。透过利用该领域现有实体的专业知识和资源，研究人员可以获得尖端的定序技术、生物资讯学工具和特定领域的知识。这种合作模式促进了更全面、更有洞察力的微生物组研究，无论是在人类健康、环境科学或农业背景下，最终有助于这一新兴领域的知识进步。

按实验室类型划分：

干燥实验室

湿实验室

湿实验室在市场上占有最大份额

该报告根据实验室类型提供了详细的市场细分和分析。这包括干实验室和湿实验室。报告称，湿实验室占了最大的市场份额。湿实验室是微生物组定序初始阶段发生的物理空间。这些实验室处理实际样本、进行 DNA 萃取并准备定序。湿实验室配备了最先进的分子生物学仪器和技术，以确保微生物群落遗传物质的完整性和品质。湿实验室的科学家使用专门的方案来分离 DNA、扩增特定的兴趣区域并准备定序文库。这些精心控制的程序对于确保准确可靠的微生物组定序资料至关重要。样本製备完成后，处理后的样本将送往定序设施或干燥实验室进行进一步分析。湿实验室是微生物组研究的实践实验部门，从样本到资料的旅程从这里开始。

按应用划分：

鸟枪式定序

标靶基因定序

RNA定序

全基因组定序

其他的

鸟枪式定序占据最大市场份额

报告还提供了基于应用程式的详细市场细分和分析。这包括鸟枪定序、标靶基因定序、RNA 定序、全基因组定序等。报告称，鸟枪测序占据了最大的市场份额。它是微生物组测序服务的强大而全面的应用。在这种方法中，对微生物群落的整个遗传物质或 DNA 进行定序，而不专门针对任何基因或区域。该方法提供了样本中微生物多样性的整体视图，使研究人员能够识别存在的所有微生物并深入了解它们的功能潜力。鸟枪法定序对于探索未知或复杂的微生物组特别有用，因为它不需要事先了解感兴趣的特定基因。它广泛应用于环境研究，例如土壤和水微生物学，并且对于了解人类肠道微生物组的复杂性及其对健康的影响具有重要意义。透过阐明微生物群落的完整基因组成，鸟枪法定序有助于更深入地了解微生物在各种生态系统中的作用及其潜在应用。

按最终用户划分：

製药和生物技术公司

研究和学术机构

其他的

製药和生物技术公司主导市场

该报告提供了基于最终用户的详细市场细分和分析。这包括製药和生物技术公司、研究和学术机构等。报告称，製药和生技公司占最大部分。这些公司代表微生物组定序服务的主要最终用户。这些公司利用微生物组资料来推动药物发现、开发和治疗介入的创新。透过与专业服务提供者合作，他们可以获得尖端的定序技术和微生物组分析的专业知识。此次合作使製药和生物技术公司能够探索人类微生物组与健康之间的复杂关係，目标是确定新的药物标靶、生物标记和候选治疗药物。此外，微生物组定序有助于开发益生菌和基于微生物组的疗法，为一系列医疗状况提供潜在的解决方案。因此，製药和生物技术公司在将微生物组研究转化为切实的医疗保健进步、最终造福患者并推动生命科学领域发展方面发挥关键作用。

按地区划分：

北美洲

美国

加拿大

亚太

中国

日本

印度

韩国

澳洲

印尼

其他的

欧洲

德国

法国

英国

义大利

西班牙

俄罗斯

其他的

拉丁美洲

巴西

墨西哥

其他的

中东和非洲

北美表现出明显的主导地位，占据最大的微生物组测序服务市场份额

市场研究报告还对所有主要区域市场进行了全面分析，其中包括北美（美国和加拿大）；亚太地区（中国、日本、印度、韩国、澳洲、印尼等）；欧洲（德国、法国、英国、义大利、西班牙、俄罗斯等）；拉丁美洲（巴西、墨西哥等）；以及中东和非洲。报告称，北美占据最大的市场份额。

人们对早期诊断和疾病检测优势的认识不断加深，这是推动北美地区微生物组定序服务需求的主要因素之一。此外，大肠直肠癌（CRC）发病率的飙升有利于该地区市场的成长。除此之外，不断增长的老年人口（更容易患上严重的疾病）正在对该地区的市场产生积极影响。

由于开发新药的投资增加、广泛的研发（R&D）活动、先进技术的整合等，亚太地区预计将稳定成长。

竞争格局：

领先公司正在微生物组定序服务中采用高通量定序，以实现对大量微生物样本的同步分析，从而促进大规模研究并提供有关微生物群落组成的高解析度资料。他们还使用宏基因组学，使研究人员能够对样本中整个微生物群落的 DNA 进行测序，而无需分离单一物种，并能够全面了解微生物组。此外，关键参与者正在将人工智慧 (AI) 和机器学习 (ML) 整合到微生物组资料分析中，帮助识别模式、预测微生物相互作用并发现与健康或疾病相关的生物标誌物，从而增强复杂微生物组资料集的可解释性。

市场研究报告对竞争格局进行了全面分析。也提供了所有主要公司的详细资料。市场上的一些主要参与者包括：

BaseClear BV

临床微生物组学 A/S

Diversigen 公司（OraSure 科技公司）

梅里埃营养科学公司

Metabiomics 公司 (BioSpherex LLC)

微生物群洞察公司

微生物组治疗有限公司

分子研究有限合伙人

Molzym 有限公司

Resphera 生物科学有限责任公司

上海睿博科技（RBT）有限公司

Zymo 研究公司

（请注意，这只是关键参与者的部分列表，报告中提供了完整列表。）

最近的发展：

2022年，Diversigen Inc（OraSure Technologies Inc.）推出了针对肠道微生物组样本的宏转录组定序和分析服务。

本报告回答的关键问题

  • 2022年全球微生物组定序服务市场规模有多大
  • 2023-2028年全球微生物组定序服务市场的预期成长率是多少
  • 推动全球微生物组定序服务市场的关键因素有哪些
  • COVID-19 对全球微生物组定序服务市场有何影响
  • 基于该技术的全球微生物组定序服务市场的细分情况如何
  • 根据研究类型，全球微生物组定序服务市场的细分如何
  • 根据实验室类型，全球微生物组定序服务市场的细分如何
  • 基于应用的全球微生物组定序服务市场区隔如何
  • 基于最终用户的全球微生物组定序服务市场的细分是什么
  • 10. 全球微生物组定序服务市场的关键区域有哪些？
  • 11. 全球微生物组定序服务市场的主要参与者/公司有哪些？

本报告回答的关键问题

  • 2022 年全球微生物组定序服务市场规模有多大？
  • 2023-2028年全球微生物组定序服务市场的预期成长率是多少？
  • 推动全球微生物组定序服务市场的关键因素是什么？
  • COVID-19 对全球微生物组定序服务市场有何影响？
  • 基于该技术的全球微生物组定序服务市场的细分情况如何？
  • 根据研究类型，全球微生物组定序服务市场的细分如何？
  • 根据实验室类型，全球微生物组定序服务市场的细分如何？
  • 基于应用的全球微生物组定序服务市场的细分情况如何？
  • 基于最终用户的全球微生物组定序服务市场的细分情况如何？
  • 全球微生物组定序服务市场的关键区域有哪些？
  • 全球微生物组定序服务市场的主要参与者/公司有哪些？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球微生物定序服务市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：依科技分類的市场

  • 边合成边定序 (SBS)
    • 市场走向
    • 市场预测
  • 连接定序 (SBL)
    • 市场走向
    • 市场预测
  • 焦磷酸定序
    • 市场走向
    • 市场预测
  • 桑格定序
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 7 章：按研究类型分類的市场细分

  • 外包研究
    • 市场走向
    • 市场预测
  • 内部研究
    • 市场走向
    • 市场预测

第 8 章：按实验室类型分類的市场细分

  • 干燥实验室
    • 市场走向
    • 市场预测
  • 湿实验室
    • 市场走向
    • 市场预测

第 9 章：按应用分類的市场区隔

  • 鸟枪式定序
    • 市场走向
    • 市场预测
  • 标靶基因定序
    • 市场走向
    • 市场预测
  • RNA定序
    • 市场走向
    • 市场预测
  • 全基因组定序
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 10 章：最终用户的市场区隔

  • 製药和生物技术公司
    • 市场走向
    • 市场预测
  • 研究和学术机构
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 11 章：按地区分類的市场细分

  • 北美洲
    • 美国
      • 市场走向
      • 市场预测
    • 加拿大
      • 市场走向
      • 市场预测
  • 亚太
    • 中国
      • 市场走向
      • 市场预测
    • 日本
      • 市场走向
      • 市场预测
    • 印度
      • 市场走向
      • 市场预测
    • 韩国
      • 市场走向
      • 市场预测
    • 澳洲
      • 市场走向
      • 市场预测
    • 印尼
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 欧洲
    • 德国
      • 市场走向
      • 市场预测
    • 法国
      • 市场走向
      • 市场预测
    • 英国
      • 市场走向
      • 市场预测
    • 义大利
      • 市场走向
      • 市场预测
    • 西班牙
      • 市场走向
      • 市场预测
    • 俄罗斯
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 拉丁美洲
    • 巴西
      • 市场走向
      • 市场预测
    • 墨西哥
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 中东和非洲
    • 市场走向
    • 按国家/地区分類的市场细分
    • 市场预测

第 12 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 13 章：价值链分析

第 14 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 15 章：价格分析

第16章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • BaseClear BV
    • Clinical-Microbiomics A/S
    • Diversigen Inc (OraSure Technologies Inc.)
    • Merieux NutriSciences
    • Metabiomics Corporation (BioSpherex LLC)
    • Microbiome Insights Inc.
    • Microbiome Therapeutics LLC
    • Molecular Research LP
    • Molzym GmbH & Co. KG
    • Resphera Biosciences LLC
    • Shanghai Realbio Technology (RBT) Co. Ltd.
    • Zymo Research Corporation
Product Code: SR112023A4357

Abstract

The global microbiome sequencing services market size reached US$ 1,846.3 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 5,568.4 Million by 2028, exhibiting a growth rate (CAGR) of 20.20% during 2022-2028. The increasing incidences of infectious diseases among the masses, rising inclination towards microbiome-based therapeutics, including FMT, and the growing adoption of microbiome sequencing in veterinary medicine are some of the major factors propelling the market.

Microbiome sequencing services involve the analysis of microbial communities that inhabit various environments, including the human body. They are specialized procedures designed to identify and analyze the diverse microorganisms living in a particular ecosystem, such as the human gut, soil, or water. They use advanced deoxyribonucleic acid (DNA) sequencing technologies to decode the genetic material of microorganisms, which allows researchers and healthcare professionals to understand the composition, diversity, and function of these microbial communities.

Increasing incidences of infectious diseases among the masses are catalyzing the demand for microbiome sequencing services for studying host-pathogen relationships, which lead to rising demand for its services around the world. Moreover, the rising inclination towards microbiome-based therapeutics, including fecal microbiota transplantation (FMT), that necessitates accurate microbiome profiling to ensure treatment efficacy and safety is favoring the growth of the market. Apart from this, the growing adoption of microbiome sequencing in veterinary medicine for understanding animal health, disease prevention, and improving livestock production is influencing the market positively. In addition, the expansion of the pharmaceutical industry is driving the use of microbiome data to develop novel drugs, particularly those targeting gastrointestinal diseases, which is contributing to the market growth. Furthermore, the increasing adoption of precision agriculture practices, which rely on data-driven decision-making, is bolstering the market growth.

Microbiome Sequencing Services Market Trends/Drivers:

Increase in personalized medicine and therapies

With the rising use of personalized medicine, there is a rise in the demand for microbiome sequencing services to offer tailoring treatments and interventions to individual patients. One of the driving forces behind the demand for microbiome sequencing services is the recognition that each microbiome of a person is unique and can significantly impact their response to treatments. Whether it is optimizing probiotic regimens, guiding dietary recommendations, or predicting drug efficacy, microbiome data is indispensable. Patients and healthcare providers increasingly seek these insights to achieve better treatment outcomes, minimize adverse effects, and enhance overall wellness. Consequently, the demand for microbiome sequencing services is rising as personalized medicine is becoming a central tenet of modern healthcare.

Rise in consumer awareness and wellness

Consumer awareness about the role of microbiomes in health and wellness has been steadily increasing. People are becoming more proactive about their health, seeking ways to optimize their microbiomes for improved well-being. This trend is driven by the availability of direct-to-consumer microbiome testing kits that provide individuals with insights into their gut microbiota. As consumers gain a better understanding of the connections between their microbiome and various health aspects, they are turning to microbiome sequencing services for in-depth analysis and personalized recommendations. This surge in interest from the public is propelling the demand for microbiome sequencing services, as individuals seek to make informed lifestyle choices and dietary adjustments to promote a healthier microbiome.

Growing regulatory requirements and quality assurance

Regulatory bodies in healthcare, agriculture, and food safety are increasingly recognizing the importance of microbiome data in ensuring safety and quality standards. For instance, in the food industry, microbiome sequencing is used to monitor and improve food safety by identifying potential pathogens or spoilage organisms. Similarly, regulatory agencies in agriculture may require microbiome assessments to ensure sustainable farming practices. Compliance with these regulations necessitates the utilization of microbiome sequencing services to maintain high-quality standards, leading to a consistent demand from businesses and organizations striving to meet regulatory requirements and ensure the safety of their products.

Microbiome Sequencing Services Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market report, along with forecasts at the global, regional, and country levels from 2023-2028. Our report has categorized the market based on technology, research type, laboratory type, application, and end user.

Breakup by Technology:

Sequencing by Synthesis (SBS)

Sequencing by Ligation (SBL)

Pyrosequencing

Sanger Sequencing

Others

Sequencing by synthesis (SBS) dominates the market

The report has provided a detailed breakup and analysis of the market based on the technology. This includes sequencing by synthesis (SBS), sequencing by ligation (SBL), pyrosequencing, sanger sequencing, and others. According to the report, sequencing by synthesis (SBS) represented the largest segment. SBS is the fundamental technology behind microbiome sequencing services. It is employed to unravel the genetic makeup of microorganisms in a given sample. During SBS, DNA strands from the microbial community are broken down into their individual components and then precisely reconstructed. This process relies on the incorporation of fluorescently labeled nucleotides into the growing DNA strands, which emit distinct signals as they are added. These signals are detected and translated into the genetic sequence, which enables scientists to identify the types and quantities of microorganisms present in the sample. SBS is highly accurate and efficient, which makes it a cornerstone of microbiome analysis, with applications ranging from human health research to environmental monitoring.

Breakup by Research Type:

Outsourced Research

Internal Research

Outsourced research holds the largest share in the market

A detailed breakup and analysis of the market based on the research type has also been provided in the report. This includes outsourced research and internal research. According to the report, outsourced research accounted for the largest market share. In the realm of microbiome sequencing services, research frequently encompasses an outsourced approach. This entails collaborating with external research partners or specialized service providers who possess advanced capabilities in microbiome analysis. These outsourced research endeavors are driven by the complexity and technical demands of microbiome studies. By leveraging the expertise and resources of established entities in this field, researchers can access cutting-edge sequencing technologies, bioinformatics tools, and domain-specific knowledge. This collaborative model fosters more comprehensive and insightful microbiome investigations, whether in the context of human health, environmental science, or agriculture, ultimately contributing to the advancement of knowledge in this burgeoning field.

Breakup by Laboratory Type:

Dry Labs

Wet Labs

Wet labs hold the largest share in the market

The report has provided a detailed breakup and analysis of the market based on the laboratory type. This includes dry labs and wet labs. According to the report, wet labs accounted for the largest market share. Wet labs are the physical spaces wherein the initial stages of microbiome sequencing occur. These labs handle the actual samples, perform DNA extraction, and prepare them for sequencing. Wet labs are equipped with state-of-the-art molecular biology instruments and techniques to ensure the integrity and quality of the genetic material from microbial communities. Scientists in wet labs use specialized protocols to isolate DNA, amplify specific regions of interest, and prepare sequencing libraries. These meticulously controlled procedures are essential to ensure accurate and reliable microbiome sequencing data. Once the sample preparation is complete, the processed samples are sent to sequencing facilities or dry labs for further analysis. Wet labs are the hands-on, experimental arm of microbiome research, where the journey from sample to data begins.

Breakup by Application:

Shotgun Sequencing

Targeted Gene Sequencing

RNA Sequencing

Whole Genome Sequencing

Others

Shotgun sequencing holds the largest share in the market

A detailed breakup and analysis of the market based on the application has also been provided in the report. This includes shotgun sequencing, targeted gene sequencing, RNA sequencing, whole genome sequencing, and others. According to the report, shotgun sequencing accounted for the largest market share. It is a powerful and comprehensive application of microbiome sequencing services. In this approach, the entire genetic material, or DNA, of a microbial community is sequenced without specifically targeting any genes or regions. This method provides a holistic view of the microbial diversity within a sample, which allows researchers to identify all the microorganisms present and gain insights into their functional potential. Shotgun sequencing is particularly useful for exploring unknown or complex microbiomes, as it does not require prior knowledge of the specific genes of interest. It is widely applied in environmental studies, such as soil and water microbiology, and has significant relevance in understanding the human gut microbiome's complexity and its implications for health. By elucidating the complete genetic makeup of microbial communities, shotgun sequencing contributes to a deeper understanding of their roles in various ecosystems and their potential applications.

Breakup by End User:

Pharmaceutical and Biotechnology Companies

Research and Academic Institutes

Others

Pharmaceutical and biotechnology companies dominate the market

The report has provided a detailed breakup and analysis of the market based on the end user. This includes pharmaceutical and biotechnology companies, research and academic institutes, and others. According to the report, pharmaceutical and biotechnology companies represented the largest segment. These companies represent key end users of microbiome sequencing services. These companies leverage microbiome data to drive innovation in drug discovery, development, and therapeutic interventions. By partnering with specialized service providers, they gain access to cutting-edge sequencing technologies and expertise in microbiome analysis. This collaboration enables pharmaceutical and biotechnology companies to explore the intricate relationship between the human microbiome and health with the goal of identifying novel drug targets, biomarkers, and therapeutic candidates. Additionally, microbiome sequencing aids in the development of probiotics and microbiome-based therapies, which offer potential solutions for a range of medical conditions. As such, pharmaceutical and biotechnology firms play a pivotal role in translating microbiome research into tangible healthcare advancements, ultimately benefiting patients and advancing the field of life sciences.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America exhibits a clear dominance, accounting for the largest microbiome sequencing services market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

The increasing knowledge about the advantages of early diagnosis and disease detection represents one of the primary factors driving the demand for microbiome sequencing services in the North American region. Moreover, the surging prevalence of colorectal cancer (CRC) is favoring the growth of the market in the region. Besides this, the growing geriatric population, that are more prone to develop severe medical conditions, is influencing the market positively in the region.

Asia Pacific is estimated to witness stable growth, owing to increasing investment in developing novel drugs, extensive research and development (R&D) activities, integration of advanced technologies, etc.

Competitive Landscape:

The leading companies are adopting the use of high throughput sequencing in microbiome sequencing services to enable the simultaneous analysis of numerous microbial samples, which facilitates large-scale studies and delivers high-resolution data on microbial community composition. They are also using metagenomics that allows researchers to sequence the DNA of an entire microbial community in a sample without isolating individual species and enables a holistic view of the microbiome. Moreover, key players are integrating artificial intelligence (AI) and machine learning (ML) into microbiome data analysis that help identify patterns, predict microbial interactions, and discover biomarkers associated with health or disease, which enhances the interpretability of complex microbiome datasets.

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

BaseClear B.V.

Clinical-Microbiomics A/S

Diversigen Inc (OraSure Technologies Inc.)

Merieux NutriSciences

Metabiomics Corporation (BioSpherex LLC)

Microbiome Insights Inc.

Microbiome Therapeutics LLC

Molecular Research LP

Molzym GmbH & Co. KG

Resphera Biosciences LLC

Shanghai Realbio Technology (RBT) Co. Ltd.

Zymo Research Corporation

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

Recent Developments:

In 2022, Diversigen Inc (OraSure Technologies Inc.) launched metatranscriptomic sequencing and analysis services for gut microbiome samples.

Key Questions Answered in This Report

  • 1. What was the size of the global microbiome sequencing services market in 2022?
  • 2. What is the expected growth rate of the global microbiome sequencing services market during 2023-2028?
  • 3. What are the key factors driving the global microbiome sequencing services market?
  • 4. What has been the impact of COVID-19 on the global microbiome sequencing services market?
  • 5. What is the breakup of the global microbiome sequencing services market based on the technology?
  • 6. What is the breakup of the global microbiome sequencing services market based on the research type?
  • 7. What is the breakup of the global microbiome sequencing services market based on the laboratory type?
  • 8. What is the breakup of the global microbiome sequencing services market based on the application?
  • 9. What is the breakup of the global microbiome sequencing services market based on the end user?
  • 10. What are the key regions in the global microbiome sequencing services market?
  • 11. Who are the key players/companies in the global microbiome sequencing services market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Microbiome Sequencing Services Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Technology

  • 6.1 Sequencing by Synthesis (SBS)
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Sequencing by Ligation (SBL)
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Pyrosequencing
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Sanger Sequencing
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Others
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Research Type

  • 7.1 Outsourced Research
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Internal Research
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Laboratory Type

  • 8.1 Dry Labs
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Wet Labs
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Application

  • 9.1 Shotgun Sequencing
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Targeted Gene Sequencing
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 RNA Sequencing
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Whole Genome Sequencing
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5 Others
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast

10 Market Breakup by End User

  • 10.1 Pharmaceutical and Biotechnology Companies
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Research and Academic Institutes
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Others
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 United States
      • 11.1.1.1 Market Trends
      • 11.1.1.2 Market Forecast
    • 11.1.2 Canada
      • 11.1.2.1 Market Trends
      • 11.1.2.2 Market Forecast
  • 11.2 Asia-Pacific
    • 11.2.1 China
      • 11.2.1.1 Market Trends
      • 11.2.1.2 Market Forecast
    • 11.2.2 Japan
      • 11.2.2.1 Market Trends
      • 11.2.2.2 Market Forecast
    • 11.2.3 India
      • 11.2.3.1 Market Trends
      • 11.2.3.2 Market Forecast
    • 11.2.4 South Korea
      • 11.2.4.1 Market Trends
      • 11.2.4.2 Market Forecast
    • 11.2.5 Australia
      • 11.2.5.1 Market Trends
      • 11.2.5.2 Market Forecast
    • 11.2.6 Indonesia
      • 11.2.6.1 Market Trends
      • 11.2.6.2 Market Forecast
    • 11.2.7 Others
      • 11.2.7.1 Market Trends
      • 11.2.7.2 Market Forecast
  • 11.3 Europe
    • 11.3.1 Germany
      • 11.3.1.1 Market Trends
      • 11.3.1.2 Market Forecast
    • 11.3.2 France
      • 11.3.2.1 Market Trends
      • 11.3.2.2 Market Forecast
    • 11.3.3 United Kingdom
      • 11.3.3.1 Market Trends
      • 11.3.3.2 Market Forecast
    • 11.3.4 Italy
      • 11.3.4.1 Market Trends
      • 11.3.4.2 Market Forecast
    • 11.3.5 Spain
      • 11.3.5.1 Market Trends
      • 11.3.5.2 Market Forecast
    • 11.3.6 Russia
      • 11.3.6.1 Market Trends
      • 11.3.6.2 Market Forecast
    • 11.3.7 Others
      • 11.3.7.1 Market Trends
      • 11.3.7.2 Market Forecast
  • 11.4 Latin America
    • 11.4.1 Brazil
      • 11.4.1.1 Market Trends
      • 11.4.1.2 Market Forecast
    • 11.4.2 Mexico
      • 11.4.2.1 Market Trends
      • 11.4.2.2 Market Forecast
    • 11.4.3 Others
      • 11.4.3.1 Market Trends
      • 11.4.3.2 Market Forecast
  • 11.5 Middle East and Africa
    • 11.5.1 Market Trends
    • 11.5.2 Market Breakup by Country
    • 11.5.3 Market Forecast

12 SWOT Analysis

  • 12.1 Overview
  • 12.2 Strengths
  • 12.3 Weaknesses
  • 12.4 Opportunities
  • 12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Price Analysis

16 Competitive Landscape

  • 16.1 Market Structure
  • 16.2 Key Players
  • 16.3 Profiles of Key Players
    • 16.3.1 BaseClear B.V.
      • 16.3.1.1 Company Overview
      • 16.3.1.2 Product Portfolio
    • 16.3.2 Clinical-Microbiomics A/S
      • 16.3.2.1 Company Overview
      • 16.3.2.2 Product Portfolio
    • 16.3.3 Diversigen Inc (OraSure Technologies Inc.)
      • 16.3.3.1 Company Overview
      • 16.3.3.2 Product Portfolio
    • 16.3.4 Merieux NutriSciences
      • 16.3.4.1 Company Overview
      • 16.3.4.2 Product Portfolio
    • 16.3.5 Metabiomics Corporation (BioSpherex LLC)
      • 16.3.5.1 Company Overview
      • 16.3.5.2 Product Portfolio
    • 16.3.6 Microbiome Insights Inc.
      • 16.3.6.1 Company Overview
      • 16.3.6.2 Product Portfolio
    • 16.3.7 Microbiome Therapeutics LLC
      • 16.3.7.1 Company Overview
      • 16.3.7.2 Product Portfolio
    • 16.3.8 Molecular Research LP
      • 16.3.8.1 Company Overview
      • 16.3.8.2 Product Portfolio
    • 16.3.9 Molzym GmbH & Co. KG
      • 16.3.9.1 Company Overview
      • 16.3.9.2 Product Portfolio
    • 16.3.10 Resphera Biosciences LLC
      • 16.3.10.1 Company Overview
      • 16.3.10.2 Product Portfolio
    • 16.3.11 Shanghai Realbio Technology (RBT) Co. Ltd.
      • 16.3.11.1 Company Overview
      • 16.3.11.2 Product Portfolio
    • 16.3.12 Zymo Research Corporation
      • 16.3.12.1 Company Overview
      • 16.3.12.2 Product Portfolio

List of Figures

  • Figure 1: Global: Microbiome Sequencing Services Market: Major Drivers and Challenges
  • Figure 2: Global: Microbiome Sequencing Services Market: Sales Value (in Million US$), 2017-2022
  • Figure 3: Global: Microbiome Sequencing Services Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 4: Global: Microbiome Sequencing Services Market: Breakup by Technology (in %), 2022
  • Figure 5: Global: Microbiome Sequencing Services Market: Breakup by Research Type (in %), 2022
  • Figure 6: Global: Microbiome Sequencing Services Market: Breakup by Laboratory Type (in %), 2022
  • Figure 7: Global: Microbiome Sequencing Services Market: Breakup by Application (in %), 2022
  • Figure 8: Global: Microbiome Sequencing Services Market: Breakup by End User (in %), 2022
  • Figure 9: Global: Microbiome Sequencing Services Market: Breakup by Region (in %), 2022
  • Figure 10: Global: Microbiome Sequencing Services (Sequencing by Synthesis -SBS) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Microbiome Sequencing Services (Sequencing by Synthesis -SBS) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Microbiome Sequencing Services (Sequencing by Ligation -SBL) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Microbiome Sequencing Services (Sequencing by Ligation -SBL) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Microbiome Sequencing Services (Pyrosequencing) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Microbiome Sequencing Services (Pyrosequencing) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Microbiome Sequencing Services (Sanger Sequencing) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Microbiome Sequencing Services (Sanger Sequencing) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Microbiome Sequencing Services (Other Technologies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Microbiome Sequencing Services (Other Technologies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Microbiome Sequencing Services (Outsourced Research) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Microbiome Sequencing Services (Outsourced Research) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Microbiome Sequencing Services (Internal Research) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Microbiome Sequencing Services (Internal Research) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: Microbiome Sequencing Services (Dry Labs) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: Microbiome Sequencing Services (Dry Labs) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: Global: Microbiome Sequencing Services (Wet Labs) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: Global: Microbiome Sequencing Services (Wet Labs) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: Global: Microbiome Sequencing Services (Shotgun Sequencing) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: Global: Microbiome Sequencing Services (Shotgun Sequencing) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: Global: Microbiome Sequencing Services (Targeted Gene Sequencing) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: Global: Microbiome Sequencing Services (Targeted Gene Sequencing) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: Global: Microbiome Sequencing Services (RNA Sequencing) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: Global: Microbiome Sequencing Services (RNA Sequencing) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: Global: Microbiome Sequencing Services (Whole Genome Sequencing) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: Global: Microbiome Sequencing Services (Whole Genome Sequencing) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: Global: Microbiome Sequencing Services (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: Global: Microbiome Sequencing Services (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: Global: Microbiome Sequencing Services (Pharmaceutical and Biotechnology Companies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: Global: Microbiome Sequencing Services (Pharmaceutical and Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: Global: Microbiome Sequencing Services (Research and Academic Institutes) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: Global: Microbiome Sequencing Services (Research and Academic Institutes) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: Global: Microbiome Sequencing Services (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: Global: Microbiome Sequencing Services (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: North America: Microbiome Sequencing Services Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: North America: Microbiome Sequencing Services Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: United States: Microbiome Sequencing Services Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: United States: Microbiome Sequencing Services Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: Canada: Microbiome Sequencing Services Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: Canada: Microbiome Sequencing Services Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: Asia-Pacific: Microbiome Sequencing Services Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: Asia-Pacific: Microbiome Sequencing Services Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: China: Microbiome Sequencing Services Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: China: Microbiome Sequencing Services Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: Japan: Microbiome Sequencing Services Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: Japan: Microbiome Sequencing Services Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: India: Microbiome Sequencing Services Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: India: Microbiome Sequencing Services Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: South Korea: Microbiome Sequencing Services Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: South Korea: Microbiome Sequencing Services Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: Australia: Microbiome Sequencing Services Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: Australia: Microbiome Sequencing Services Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: Indonesia: Microbiome Sequencing Services Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: Indonesia: Microbiome Sequencing Services Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: Others: Microbiome Sequencing Services Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: Others: Microbiome Sequencing Services Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: Europe: Microbiome Sequencing Services Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: Europe: Microbiome Sequencing Services Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Germany: Microbiome Sequencing Services Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: Germany: Microbiome Sequencing Services Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: France: Microbiome Sequencing Services Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: France: Microbiome Sequencing Services Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 72: United Kingdom: Microbiome Sequencing Services Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 73: United Kingdom: Microbiome Sequencing Services Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 74: Italy: Microbiome Sequencing Services Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 75: Italy: Microbiome Sequencing Services Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 76: Spain: Microbiome Sequencing Services Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 77: Spain: Microbiome Sequencing Services Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 78: Russia: Microbiome Sequencing Services Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 79: Russia: Microbiome Sequencing Services Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 80: Others: Microbiome Sequencing Services Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 81: Others: Microbiome Sequencing Services Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 82: Latin America: Microbiome Sequencing Services Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 83: Latin America: Microbiome Sequencing Services Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 84: Brazil: Microbiome Sequencing Services Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 85: Brazil: Microbiome Sequencing Services Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 86: Mexico: Microbiome Sequencing Services Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 87: Mexico: Microbiome Sequencing Services Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 88: Others: Microbiome Sequencing Services Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 89: Others: Microbiome Sequencing Services Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 90: Middle East and Africa: Microbiome Sequencing Services Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 91: Middle East and Africa: Microbiome Sequencing Services Market: Breakup by Country (in %), 2022
  • Figure 92: Middle East and Africa: Microbiome Sequencing Services Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 93: Global: Microbiome Sequencing Services Industry: SWOT Analysis
  • Figure 94: Global: Microbiome Sequencing Services Industry: Value Chain Analysis
  • Figure 95: Global: Microbiome Sequencing Services Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Microbiome Sequencing Services Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Microbiome Sequencing Services Market Forecast: Breakup by Technology (in Million US$), 2023-2028
  • Table 3: Global: Microbiome Sequencing Services Market Forecast: Breakup by Research Type (in Million US$), 2023-2028
  • Table 4: Global: Microbiome Sequencing Services Market Forecast: Breakup by Laboratory Type (in Million US$), 2023-2028
  • Table 5: Global: Microbiome Sequencing Services Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 6: Global: Microbiome Sequencing Services Market Forecast: Breakup by End User (in Million US$), 2023-2028
  • Table 7: Global: Microbiome Sequencing Services Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 8: Global: Microbiome Sequencing Services Market: Competitive Structure
  • Table 9: Global: Microbiome Sequencing Services Market: Key Players